News
03-25-2011, 04:50 AM
Protelos has significantly greater bone-forming activity than the commonly prescribed bisphosphonate, alendronate, according to results of the largest-ever biopsy study in post-menopausal women presented today at the European Congress on Osteoporosis and Osteoarthritis in Valencia.
More... (http://www.news-medical.net/news/20110325/Osteoporosis-study-Protelos-have-significant-bone-forming-activity-than-bisphosphonates.aspx)
More... (http://www.news-medical.net/news/20110325/Osteoporosis-study-Protelos-have-significant-bone-forming-activity-than-bisphosphonates.aspx)